長寿・抗老化療法の世界市場成長(現状と展望)2024-2030年Global Longevity and Anti-senescence Therapy Market Growth (Status and Outlook) 2024-2030 LPI(LPインフォメーション)の最新調査によると、世界の長寿・抗老化療法市場規模は2023年に3億1140万米ドルとなった。下流市場での需要拡大に伴い、長寿・抗老化療法は2030年までに5億4,780万米ドルの再調整規... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーLPI(LPインフォメーション)の最新調査によると、世界の長寿・抗老化療法市場規模は2023年に3億1140万米ドルとなった。下流市場での需要拡大に伴い、長寿・抗老化療法は2030年までに5億4,780万米ドルの再調整規模になると予測され、レビュー期間中のCAGRは8.4%である。この調査レポートは、世界の長寿・抗老化療法市場の成長可能性を明らかにしています。長寿・抗老化療法は今後の市場でも安定した成長が期待される。しかし、製品の差別化、コスト削減、サプライチェーンの最適化が、長寿・抗老化療法の普及に不可欠であることに変わりはありません。市場関係者は、研究開発への投資、戦略的パートナーシップの構築、進化する消費者の嗜好に合わせた製品提供などを行い、長寿・抗老化療法市場がもたらす莫大な機会を活用する必要がある。 老化は自然なプロセスであり、yixueアンチエイジングは、抑制といくつかを指し、身体の老化プロセスを遅らせ、全体的な健康を促進することができ、より良い知性と体力を維持するために、生命の限界内の遺伝的要因で体を作る。アンチエイジングは、フリーラジカルの産生を減少させ、コラーゲンや酵素、アンチエイジング食餌療法とアンチエイジングスキンケア製品を補充しながら、抗酸化物質を補充することにより、肌の弾力性を高めることが効果的に老化を遅らせることができます。 主な特徴 長寿・抗老化療法市場に関する本レポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。 市場規模と成長:この調査レポートは、長寿・抗老化療法市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分(薬物療法、遺伝子療法など)、地域別内訳などが含まれます。 市場促進要因と課題:レポートでは、政府の規制、環境問題、技術の進歩、消費者の嗜好の変化など、長寿・抗老化療法市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、射程距離への不安、高額な初期費用など、業界が直面する課題も明らかにすることができる。 競合情勢:この調査レポートは、長寿・抗老化療法市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれる。また、新興プレーヤーとその潜在的な市場への影響もハイライトできます。 技術開発:調査レポートは、長寿・抗老化療法業界における最新の技術開発を掘り下げることができます。これには、長寿・抗白髪療法技術の進歩、長寿・抗白髪療法の新規参入企業、長寿・抗白髪療法の新規投資、長寿・抗白髪療法の将来を形作るその他の技術革新が含まれます。 川下企業の好み:本レポートは、長寿・抗老化療法市場における顧客の購買行動と採用動向を明らかにすることができます。このレポートには、顧客の購買決定や長寿・抗老化療法製品の嗜好に影響を与える要因が含まれています。 政府の政策とインセンティブこの調査レポートは、政府の政策やインセンティブが長寿・抗老化療法市場に与える影響を分析している。これには、規制の枠組み、補助金、税制優遇措置、その他長寿・抗老化療法市場の促進を目的とした施策の評価が含まれる。また、市場成長を促進するためのこれらの政策の有効性についても評価する。 環境への影響と持続可能性調査レポートは、長寿・抗老化療法市場の環境への影響と持続可能性の側面を評価しています。 市場予測と将来展望:実施した分析に基づき、調査レポートは長寿・抗老化療法産業の市場予測と展望を提供します。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。 提言と機会:本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられています。市場関係者が新たなトレンドを活用し、課題を克服し、長寿・抗老化療法市場の成長と発展に貢献するための潜在的な機会を強調しています。 市場の細分化 長寿・抗老化療法市場は、タイプ別と用途別に分類される。2019年から2030年までの期間について、セグメント間の成長により、タイプ別、アプリケーション別の消費額の正確な計算と予測を提供します。 タイプ別セグメント 薬物療法 遺伝子療法 免疫療法 その他 用途別セグメント 病院 医療サービス機関 その他 本レポートは地域別にも市場を分割しています: 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 ブリストル・マイヤーズ スクイブ コーバー ライフ・バイオサイエンス エイジックス・セラピューティクス ユニティ・バイオテクノロジー キャリコ・ライフサイエンシズ オイシン・バイオテクノロジーズ T.A.サイエンシズ バイオエイジラボ レトロバイオサイエンス セノリティック・セラピューティクス 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Longevity and Anti-senescence Therapy Market Size 2019-2030 2.1.2 Longevity and Anti-senescence Therapy Market Size CAGR by Region 2019 VS 2023 VS 2030 2.2 Longevity and Anti-senescence Therapy Segment by Type 2.2.1 Drug Therapy 2.2.2 Gene Therapy 2.2.3 Immunotherapy 2.2.4 Others 2.3 Longevity and Anti-senescence Therapy Market Size by Type 2.3.1 Longevity and Anti-senescence Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Longevity and Anti-senescence Therapy Market Size Market Share by Type (2019-2024) 2.4 Longevity and Anti-senescence Therapy Segment by Application 2.4.1 Hospital 2.4.2 Medical Service Institution 2.4.3 Others 2.5 Longevity and Anti-senescence Therapy Market Size by Application 2.5.1 Longevity and Anti-senescence Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Longevity and Anti-senescence Therapy Market Size Market Share by Application (2019-2024) 3 Longevity and Anti-senescence Therapy Market Size by Player 3.1 Longevity and Anti-senescence Therapy Market Size Market Share by Players 3.1.1 Global Longevity and Anti-senescence Therapy Revenue by Players (2019-2024) 3.1.2 Global Longevity and Anti-senescence Therapy Revenue Market Share by Players (2019-2024) 3.2 Global Longevity and Anti-senescence Therapy Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Longevity and Anti-senescence Therapy by Regions 4.1 Longevity and Anti-senescence Therapy Market Size by Regions (2019-2024) 4.2 Americas Longevity and Anti-senescence Therapy Market Size Growth (2019-2024) 4.3 APAC Longevity and Anti-senescence Therapy Market Size Growth (2019-2024) 4.4 Europe Longevity and Anti-senescence Therapy Market Size Growth (2019-2024) 4.5 Middle East & Africa Longevity and Anti-senescence Therapy Market Size Growth (2019-2024) 5 Americas 5.1 Americas Longevity and Anti-senescence Therapy Market Size by Country (2019-2024) 5.2 Americas Longevity and Anti-senescence Therapy Market Size by Type (2019-2024) 5.3 Americas Longevity and Anti-senescence Therapy Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Longevity and Anti-senescence Therapy Market Size by Region (2019-2024) 6.2 APAC Longevity and Anti-senescence Therapy Market Size by Type (2019-2024) 6.3 APAC Longevity and Anti-senescence Therapy Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Longevity and Anti-senescence Therapy by Country (2019-2024) 7.2 Europe Longevity and Anti-senescence Therapy Market Size by Type (2019-2024) 7.3 Europe Longevity and Anti-senescence Therapy Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Longevity and Anti-senescence Therapy by Region (2019-2024) 8.2 Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Type (2019-2024) 8.3 Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Longevity and Anti-senescence Therapy Market Forecast 10.1 Global Longevity and Anti-senescence Therapy Forecast by Regions (2025-2030) 10.1.1 Global Longevity and Anti-senescence Therapy Forecast by Regions (2025-2030) 10.1.2 Americas Longevity and Anti-senescence Therapy Forecast 10.1.3 APAC Longevity and Anti-senescence Therapy Forecast 10.1.4 Europe Longevity and Anti-senescence Therapy Forecast 10.1.5 Middle East & Africa Longevity and Anti-senescence Therapy Forecast 10.2 Americas Longevity and Anti-senescence Therapy Forecast by Country (2025-2030) 10.2.1 United States Longevity and Anti-senescence Therapy Market Forecast 10.2.2 Canada Longevity and Anti-senescence Therapy Market Forecast 10.2.3 Mexico Longevity and Anti-senescence Therapy Market Forecast 10.2.4 Brazil Longevity and Anti-senescence Therapy Market Forecast 10.3 APAC Longevity and Anti-senescence Therapy Forecast by Region (2025-2030) 10.3.1 China Longevity and Anti-senescence Therapy Market Forecast 10.3.2 Japan Longevity and Anti-senescence Therapy Market Forecast 10.3.3 Korea Longevity and Anti-senescence Therapy Market Forecast 10.3.4 Southeast Asia Longevity and Anti-senescence Therapy Market Forecast 10.3.5 India Longevity and Anti-senescence Therapy Market Forecast 10.3.6 Australia Longevity and Anti-senescence Therapy Market Forecast 10.4 Europe Longevity and Anti-senescence Therapy Forecast by Country (2025-2030) 10.4.1 Germany Longevity and Anti-senescence Therapy Market Forecast 10.4.2 France Longevity and Anti-senescence Therapy Market Forecast 10.4.3 UK Longevity and Anti-senescence Therapy Market Forecast 10.4.4 Italy Longevity and Anti-senescence Therapy Market Forecast 10.4.5 Russia Longevity and Anti-senescence Therapy Market Forecast 10.5 Middle East & Africa Longevity and Anti-senescence Therapy Forecast by Region (2025-2030) 10.5.1 Egypt Longevity and Anti-senescence Therapy Market Forecast 10.5.2 South Africa Longevity and Anti-senescence Therapy Market Forecast 10.5.3 Israel Longevity and Anti-senescence Therapy Market Forecast 10.5.4 Turkey Longevity and Anti-senescence Therapy Market Forecast 10.5.5 GCC Countries Longevity and Anti-senescence Therapy Market Forecast 10.6 Global Longevity and Anti-senescence Therapy Forecast by Type (2025-2030) 10.7 Global Longevity and Anti-senescence Therapy Forecast by Application (2025-2030) 11 Key Players Analysis 11.1 Bristol Myers Squibb 11.1.1 Bristol Myers Squibb Company Information 11.1.2 Bristol Myers Squibb Longevity and Anti-senescence Therapy Product Offered 11.1.3 Bristol Myers Squibb Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 Bristol Myers Squibb Main Business Overview 11.1.5 Bristol Myers Squibb Latest Developments 11.2 CohBar 11.2.1 CohBar Company Information 11.2.2 CohBar Longevity and Anti-senescence Therapy Product Offered 11.2.3 CohBar Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 CohBar Main Business Overview 11.2.5 CohBar Latest Developments 11.3 Life Biosciences 11.3.1 Life Biosciences Company Information 11.3.2 Life Biosciences Longevity and Anti-senescence Therapy Product Offered 11.3.3 Life Biosciences Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 Life Biosciences Main Business Overview 11.3.5 Life Biosciences Latest Developments 11.4 AgeX Therapeutics 11.4.1 AgeX Therapeutics Company Information 11.4.2 AgeX Therapeutics Longevity and Anti-senescence Therapy Product Offered 11.4.3 AgeX Therapeutics Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 AgeX Therapeutics Main Business Overview 11.4.5 AgeX Therapeutics Latest Developments 11.5 Unity Biotechnology 11.5.1 Unity Biotechnology Company Information 11.5.2 Unity Biotechnology Longevity and Anti-senescence Therapy Product Offered 11.5.3 Unity Biotechnology Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 Unity Biotechnology Main Business Overview 11.5.5 Unity Biotechnology Latest Developments 11.6 Calico Life Sciences 11.6.1 Calico Life Sciences Company Information 11.6.2 Calico Life Sciences Longevity and Anti-senescence Therapy Product Offered 11.6.3 Calico Life Sciences Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 Calico Life Sciences Main Business Overview 11.6.5 Calico Life Sciences Latest Developments 11.7 Oisin Biotechnologies 11.7.1 Oisin Biotechnologies Company Information 11.7.2 Oisin Biotechnologies Longevity and Anti-senescence Therapy Product Offered 11.7.3 Oisin Biotechnologies Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 Oisin Biotechnologies Main Business Overview 11.7.5 Oisin Biotechnologies Latest Developments 11.8 T.A. Sciences 11.8.1 T.A. Sciences Company Information 11.8.2 T.A. Sciences Longevity and Anti-senescence Therapy Product Offered 11.8.3 T.A. Sciences Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 T.A. Sciences Main Business Overview 11.8.5 T.A. Sciences Latest Developments 11.9 BioAge Labs 11.9.1 BioAge Labs Company Information 11.9.2 BioAge Labs Longevity and Anti-senescence Therapy Product Offered 11.9.3 BioAge Labs Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.9.4 BioAge Labs Main Business Overview 11.9.5 BioAge Labs Latest Developments 11.10 Retro Biosciences 11.10.1 Retro Biosciences Company Information 11.10.2 Retro Biosciences Longevity and Anti-senescence Therapy Product Offered 11.10.3 Retro Biosciences Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.10.4 Retro Biosciences Main Business Overview 11.10.5 Retro Biosciences Latest Developments 11.11 Senolytic Therapeutics 11.11.1 Senolytic Therapeutics Company Information 11.11.2 Senolytic Therapeutics Longevity and Anti-senescence Therapy Product Offered 11.11.3 Senolytic Therapeutics Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.11.4 Senolytic Therapeutics Main Business Overview 11.11.5 Senolytic Therapeutics Latest Developments 12 Research Findings and Conclusion
SummaryAccording to our LPI (LP Information) latest study, the global Longevity and Anti-senescence Therapy market size was valued at US$ 311.4 million in 2023. With growing demand in downstream market, the Longevity and Anti-senescence Therapy is forecast to a readjusted size of US$ 547.8 million by 2030 with a CAGR of 8.4% during review period. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Longevity and Anti-senescence Therapy Market Size 2019-2030 2.1.2 Longevity and Anti-senescence Therapy Market Size CAGR by Region 2019 VS 2023 VS 2030 2.2 Longevity and Anti-senescence Therapy Segment by Type 2.2.1 Drug Therapy 2.2.2 Gene Therapy 2.2.3 Immunotherapy 2.2.4 Others 2.3 Longevity and Anti-senescence Therapy Market Size by Type 2.3.1 Longevity and Anti-senescence Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Longevity and Anti-senescence Therapy Market Size Market Share by Type (2019-2024) 2.4 Longevity and Anti-senescence Therapy Segment by Application 2.4.1 Hospital 2.4.2 Medical Service Institution 2.4.3 Others 2.5 Longevity and Anti-senescence Therapy Market Size by Application 2.5.1 Longevity and Anti-senescence Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Longevity and Anti-senescence Therapy Market Size Market Share by Application (2019-2024) 3 Longevity and Anti-senescence Therapy Market Size by Player 3.1 Longevity and Anti-senescence Therapy Market Size Market Share by Players 3.1.1 Global Longevity and Anti-senescence Therapy Revenue by Players (2019-2024) 3.1.2 Global Longevity and Anti-senescence Therapy Revenue Market Share by Players (2019-2024) 3.2 Global Longevity and Anti-senescence Therapy Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Longevity and Anti-senescence Therapy by Regions 4.1 Longevity and Anti-senescence Therapy Market Size by Regions (2019-2024) 4.2 Americas Longevity and Anti-senescence Therapy Market Size Growth (2019-2024) 4.3 APAC Longevity and Anti-senescence Therapy Market Size Growth (2019-2024) 4.4 Europe Longevity and Anti-senescence Therapy Market Size Growth (2019-2024) 4.5 Middle East & Africa Longevity and Anti-senescence Therapy Market Size Growth (2019-2024) 5 Americas 5.1 Americas Longevity and Anti-senescence Therapy Market Size by Country (2019-2024) 5.2 Americas Longevity and Anti-senescence Therapy Market Size by Type (2019-2024) 5.3 Americas Longevity and Anti-senescence Therapy Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Longevity and Anti-senescence Therapy Market Size by Region (2019-2024) 6.2 APAC Longevity and Anti-senescence Therapy Market Size by Type (2019-2024) 6.3 APAC Longevity and Anti-senescence Therapy Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Longevity and Anti-senescence Therapy by Country (2019-2024) 7.2 Europe Longevity and Anti-senescence Therapy Market Size by Type (2019-2024) 7.3 Europe Longevity and Anti-senescence Therapy Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Longevity and Anti-senescence Therapy by Region (2019-2024) 8.2 Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Type (2019-2024) 8.3 Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Longevity and Anti-senescence Therapy Market Forecast 10.1 Global Longevity and Anti-senescence Therapy Forecast by Regions (2025-2030) 10.1.1 Global Longevity and Anti-senescence Therapy Forecast by Regions (2025-2030) 10.1.2 Americas Longevity and Anti-senescence Therapy Forecast 10.1.3 APAC Longevity and Anti-senescence Therapy Forecast 10.1.4 Europe Longevity and Anti-senescence Therapy Forecast 10.1.5 Middle East & Africa Longevity and Anti-senescence Therapy Forecast 10.2 Americas Longevity and Anti-senescence Therapy Forecast by Country (2025-2030) 10.2.1 United States Longevity and Anti-senescence Therapy Market Forecast 10.2.2 Canada Longevity and Anti-senescence Therapy Market Forecast 10.2.3 Mexico Longevity and Anti-senescence Therapy Market Forecast 10.2.4 Brazil Longevity and Anti-senescence Therapy Market Forecast 10.3 APAC Longevity and Anti-senescence Therapy Forecast by Region (2025-2030) 10.3.1 China Longevity and Anti-senescence Therapy Market Forecast 10.3.2 Japan Longevity and Anti-senescence Therapy Market Forecast 10.3.3 Korea Longevity and Anti-senescence Therapy Market Forecast 10.3.4 Southeast Asia Longevity and Anti-senescence Therapy Market Forecast 10.3.5 India Longevity and Anti-senescence Therapy Market Forecast 10.3.6 Australia Longevity and Anti-senescence Therapy Market Forecast 10.4 Europe Longevity and Anti-senescence Therapy Forecast by Country (2025-2030) 10.4.1 Germany Longevity and Anti-senescence Therapy Market Forecast 10.4.2 France Longevity and Anti-senescence Therapy Market Forecast 10.4.3 UK Longevity and Anti-senescence Therapy Market Forecast 10.4.4 Italy Longevity and Anti-senescence Therapy Market Forecast 10.4.5 Russia Longevity and Anti-senescence Therapy Market Forecast 10.5 Middle East & Africa Longevity and Anti-senescence Therapy Forecast by Region (2025-2030) 10.5.1 Egypt Longevity and Anti-senescence Therapy Market Forecast 10.5.2 South Africa Longevity and Anti-senescence Therapy Market Forecast 10.5.3 Israel Longevity and Anti-senescence Therapy Market Forecast 10.5.4 Turkey Longevity and Anti-senescence Therapy Market Forecast 10.5.5 GCC Countries Longevity and Anti-senescence Therapy Market Forecast 10.6 Global Longevity and Anti-senescence Therapy Forecast by Type (2025-2030) 10.7 Global Longevity and Anti-senescence Therapy Forecast by Application (2025-2030) 11 Key Players Analysis 11.1 Bristol Myers Squibb 11.1.1 Bristol Myers Squibb Company Information 11.1.2 Bristol Myers Squibb Longevity and Anti-senescence Therapy Product Offered 11.1.3 Bristol Myers Squibb Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 Bristol Myers Squibb Main Business Overview 11.1.5 Bristol Myers Squibb Latest Developments 11.2 CohBar 11.2.1 CohBar Company Information 11.2.2 CohBar Longevity and Anti-senescence Therapy Product Offered 11.2.3 CohBar Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 CohBar Main Business Overview 11.2.5 CohBar Latest Developments 11.3 Life Biosciences 11.3.1 Life Biosciences Company Information 11.3.2 Life Biosciences Longevity and Anti-senescence Therapy Product Offered 11.3.3 Life Biosciences Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 Life Biosciences Main Business Overview 11.3.5 Life Biosciences Latest Developments 11.4 AgeX Therapeutics 11.4.1 AgeX Therapeutics Company Information 11.4.2 AgeX Therapeutics Longevity and Anti-senescence Therapy Product Offered 11.4.3 AgeX Therapeutics Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 AgeX Therapeutics Main Business Overview 11.4.5 AgeX Therapeutics Latest Developments 11.5 Unity Biotechnology 11.5.1 Unity Biotechnology Company Information 11.5.2 Unity Biotechnology Longevity and Anti-senescence Therapy Product Offered 11.5.3 Unity Biotechnology Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 Unity Biotechnology Main Business Overview 11.5.5 Unity Biotechnology Latest Developments 11.6 Calico Life Sciences 11.6.1 Calico Life Sciences Company Information 11.6.2 Calico Life Sciences Longevity and Anti-senescence Therapy Product Offered 11.6.3 Calico Life Sciences Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 Calico Life Sciences Main Business Overview 11.6.5 Calico Life Sciences Latest Developments 11.7 Oisin Biotechnologies 11.7.1 Oisin Biotechnologies Company Information 11.7.2 Oisin Biotechnologies Longevity and Anti-senescence Therapy Product Offered 11.7.3 Oisin Biotechnologies Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 Oisin Biotechnologies Main Business Overview 11.7.5 Oisin Biotechnologies Latest Developments 11.8 T.A. Sciences 11.8.1 T.A. Sciences Company Information 11.8.2 T.A. Sciences Longevity and Anti-senescence Therapy Product Offered 11.8.3 T.A. Sciences Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 T.A. Sciences Main Business Overview 11.8.5 T.A. Sciences Latest Developments 11.9 BioAge Labs 11.9.1 BioAge Labs Company Information 11.9.2 BioAge Labs Longevity and Anti-senescence Therapy Product Offered 11.9.3 BioAge Labs Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.9.4 BioAge Labs Main Business Overview 11.9.5 BioAge Labs Latest Developments 11.10 Retro Biosciences 11.10.1 Retro Biosciences Company Information 11.10.2 Retro Biosciences Longevity and Anti-senescence Therapy Product Offered 11.10.3 Retro Biosciences Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.10.4 Retro Biosciences Main Business Overview 11.10.5 Retro Biosciences Latest Developments 11.11 Senolytic Therapeutics 11.11.1 Senolytic Therapeutics Company Information 11.11.2 Senolytic Therapeutics Longevity and Anti-senescence Therapy Product Offered 11.11.3 Senolytic Therapeutics Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.11.4 Senolytic Therapeutics Main Business Overview 11.11.5 Senolytic Therapeutics Latest Developments 12 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
LP Information社の医療分野での最新刊レポート本レポートと同じKEY WORD(antisenescence therapy)の最新刊レポートよくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |